-
of this British Heart Foundation funded project will especially investigate vascular smooth muscle cell mechanosensing and phenotypic switching, following up on previous work of the Iskratsch Group and
-
proteomic and metabolomic techniques to investigate the impact of inhibiting glutamine metabolism in lymphoma cell lines and primary human cells. In addition, a component of the work will involve the use
-
including cell culture, organ-chip models, tissue engineering, and musculoskeletal biology. The PDRA will plan and conduct experiments, generate high-quality data, prepare publications, make presentations and
-
combined CTC, ctDNA and immune factors. This will also provide information of the interaction between cancer cells, CTCs and the host immune system in determining perioperative cancer cell fate, opening a
-
biomedical sciences backgrounds combining expertise in organ-chip technology, cell biology, bioengineering and bio fabrication, with a collective aim to better understand tendon physiology and disease. About
-
of Spiralian Asymmetric Cell Divisions”. This research position will reveal the mechanisms that drive the evolution of polar lobes during the first asymmetric cell divisions in animals with spiral cleavage. We
-
of pediatric brain tumours (Vinel et al BMC Biology 2025, Constantinou et al Cell Reports 2024 and Vinel et al. Nature Communications 2021) to develop new personalised therapies. About You We seek an ambitious
-
for an outstanding, post-doctoral researcher with proven expertise and practical experience in relevant techniques including cell culture, organ-chip models, tissue engineering, and musculoskeletal biology. The PDRA
-
& adaptive immunity. Our scientific research spans cellular and molecular biology, immunology, pharmacology, antibody engineering, chemistry and structure-function relationships, as well as bioinformatics